ZEB1 and colorectal cancer: These results obtained from colorectal cancer patients may support the findings in the cell and animal model, and indicated that activation of the β-catenin/ZEB1 axis by DDX3 overexpression may promote tumor invasion and consequently result in poorer outcome in colorectal cancer patients.